000 01309 a2200397 4500
005 20250515182659.0
264 0 _c20090825
008 200908s 0 0 eng d
022 _a1941-9260
024 7 _a10.3810/pgm.09.1.2000.suppl6.37
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJamieson, D G
245 0 0 _aRizatriptan. Comparative trial results.
_h[electronic resource]
260 _bPostgraduate medicine
_cSep 2000
300 _a22-8 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMigraine Disorders
_xdrug therapy
650 0 4 _aOxazolidinones
_xtherapeutic use
650 0 4 _aPiperidines
_xtherapeutic use
650 0 4 _aSerotonin Receptor Agonists
_xtherapeutic use
650 0 4 _aTime Factors
650 0 4 _aTreatment Outcome
650 0 4 _aTriazoles
_xtherapeutic use
650 0 4 _aTryptamines
_xtherapeutic use
650 0 4 _aVasoconstrictor Agents
_xtherapeutic use
650 0 4 _aYoung Adult
773 0 _tPostgraduate medicine
_gvol. 108
_gno. 3 Suppl
_gp. 22-8
856 4 0 _uhttps://doi.org/10.3810/pgm.09.1.2000.suppl6.37
_zAvailable from publisher's website
999 _c19073835
_d19073835